Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. NCI NIH HHS [P01 CA155258] Funding Source: Medline
2. NATIONAL CANCER INSTITUTE [P01CA155258] Funding Source: NIH RePORTER